Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Metabolic screening in children receiving antipsychotic drug treatment
Elaine H. Morrato
,
Ginger E. Nicol
, David Maahs
, Benjamin G. Druss
, Daniel M. Hartung
, Robert J. Valuck
, Elizabeth Campagna
, John W. Newcomer
Institute of Clinical and Translational Sciences (ICTS)
mHealth Research Core
Intellectual and Developmental Disabilities Research Center (IDDRC)
Division of Clinical Neuroscience and Behavioral Health Research
Research output
:
Contribution to journal
›
Article
›
peer-review
139
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Metabolic screening in children receiving antipsychotic drug treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antipsychotics
100%
Second-generation Antipsychotics
100%
Metabolic Screening
100%
Confidence Interval
62%
Without Diabetes
25%
Albuterol
25%
Lipid Testing
25%
Glucose Screening
25%
Dyslipidemia
12%
Psychiatric Diagnosis
12%
Serum Lipids
12%
Blood Glucose
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Logistic Regression Analysis
12%
Missouri
12%
Screening Rate
12%
American Psychiatric Association
12%
Diabetes Incidence
12%
Health Care Services
12%
Lipid Disorders
12%
Glucose Testing
12%
Oregon
12%
Metabolic Disturbances
12%
American Diabetes Association
12%
New User
12%
Starting Treatment
12%
Medicaid Claims Data
12%
Glucose Disorders
12%
Public Sector
12%
Lipid Screening
12%
Medicine and Dentistry
Pharmacotherapy
100%
Antipsychotic
100%
Diabetes
50%
Antipsychotic Drug
50%
Salbutamol
33%
Health Care
16%
Multivariate Logistic Regression Analysis
16%
Cohort Analysis
16%
Disease
16%
Dyslipidemia
16%
Diabetes Mellitus
16%
Water-Electrolyte Imbalance
16%
Lipid Analysis
16%
Psychiatric Diagnosis
16%
Nursing and Health Professions
Confidence Interval
100%
Drug Therapy
100%
Salbutamol
40%
Cohort Analysis
20%
Glucose Blood Level
20%
Diabetes Mellitus
20%
Lipid Blood Level
20%
Multivariate Logistic Regression Analysis
20%
Dyslipidemia
20%
Psychiatric Diagnosis
20%
Lipid Analysis
20%
Health Care
20%
Metabolic Disorder
20%